Oncotarget

Research Papers:

RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer

Mingxin Zuo, Asif Rashid, Ying Wang, Apurva Jain, Donghui Li, Anu Behari, Vinay Kumar Kapoor, Eugene J. Koay, Ping Chang, Jean Nicholas Vauthey, Yanan Li, Jaime A. Espinoza, Juan Carlos Roa and Milind Javle _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:35302-35312. https://doi.org/10.18632/oncotarget.9181

Metrics: HTML 974 views  |   ?  


Abstract

Mingxin Zuo1, Asif Rashid2, Ying Wang3, Apurva Jain1, Donghui Li1, Anu Behari4, Vinay Kumar Kapoor4, Eugene J. Koay5, Ping Chang1, Jean Nicholas Vauthey6, Yanan Li1, Jaime A. Espinoza7, Juan Carlos Roa8, Milind Javle1

1Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

2Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

3Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

4Department of Surgical Gastroenterology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences (SGPGIMS), Lucknow, UP, India

5Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

6Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

7SciLifeLab, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Stockholm, Sweden

8Department of Pathology, Advanced Center for Chronic Diseases (ACCDiS), UC-Center for Investigational Oncology (CITO), School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Correspondence to:

Milind Javle, email: mjavle@mdanderson.org

Keywords: RNA sequence, gallbladder cancer, liver X receptor, lipid metabolism pathways

Received: February 12, 2016     Accepted: April 16, 2016     Published: May 5, 2016

ABSTRACT

Gallbladder cancer (GBC) is an aggressive malignancy. Although surgical resection may be curable, most patients are diagnosed at an advanced unresectable disease stage. Cholelithiasis is the major risk factor; however the pathogenesis of the disease, from gallstone cholecystitis to cancer, is still not understood. To understand the molecular genetic underpinnings of this cancer and explore novel therapeutic targets for GBC, we examined the key genes and pathways involved in GBC using RNA sequencing. We performed gene expression analysis of 32 cases of surgically-resected GBC along with normal gallbladder tissue controls. We observed that 519 genes were differentially expressed between GBC and normal GB mucosal controls. The liver X receptor (LXR)/retinoid X receptor (RXR) and farnesoid X receptor (FXR) /RXR pathways were the top canonical pathways involved in GBC. Key genes in these pathways, including SERPINB3 and KLK1, were overexpressed in GBC, especially in female GBC patients. Additionally, ApoA1 gene expression suppressed in GBC as compared with normal control tissues. LXR and FXR genes, known to be important in lipid metabolism also function as tumor suppressors and their down regulation appears to be critical for GBC pathogenesis. LXR agonists may have therapeutic value and as potential therapeutic targets.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 9181